Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
2369 On Other Exchanges
Symbol
Exchange
2369 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

medibic group (2369) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIBIC GROUP (2369)

Related News

No related news articles were found.

medibic group (2369) Related Businessweek News

No Related Businessweek News Found

medibic group (2369) Details

MediBIC Group provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; the research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group was founded in 2000 and is headquartered in Tokyo, Japan.

29 Employees
Last Reported Date: 03/30/15
Founded in 2000

medibic group (2369) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medibic group (2369) Key Developments

MediBIC Group to Report Fiscal Year 2015 Results on Feb 12, 2016

MediBIC Group announced that they will report fiscal year 2015 results on Feb 12, 2016

MediBIC Group Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2015

MediBIC Group reported consolidated earnings results for the nine months ended September 30, 2015. For the period, net sales were JPY 60 million against JPY 103 million a year ago. Operating loss was JPY 351 million against JPY 354 million a year ago. Ordinary loss was JPY 413 million against JPY 357 million a year ago. Net loss was JPY 477 million or JPY 16.29 per share against JPY 393 million or JPY 13.63 per share a year ago. For the fiscal year ending December 31, 2015, the company expects on consolidated basis, net sales of JPY 101 million, operating loss of JPY 448 million, ordinary loss of JPY 510 million and net loss of JPY 644 million or JPY 21.94 per share.

MediBIC Group to Report Q3, 2015 Results on Nov 11, 2015

MediBIC Group announced that they will report Q3, 2015 results on Nov 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2369:JP ¥144.00 JPY -17.00

2369 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2369.
View Industry Companies
 

Industry Analysis

2369

Industry Average

Valuation 2369 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.8x
Price/Book 8.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MEDIBIC GROUP, please visit www.medibic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.